It could therefore be that the activation of RAS through the functional loss of neurofibromin (due to NF1 gene inactivation) gives rise to the overexpression of SPP1. Furthermore, the use of SPP1 inhibitors such as agelastatin A has successfully reduced colony formation, migration and invasion in human breast cancer cell lines [51]. The gene discussed is SPP1; the disease is breast carcinoma.